1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Regions in which conventional VBM identified significantly reduced GM: comparisons between patients and healthy controls
Comparison and Brain Region Talairach Coordinates t Value Side X Y Z Patients with DLB < controls Amygdala Rt 14 0 −15 9.14 Amygdala Rt −14 0 15 7.84 Inferior temporal gyrus Rt 60 −19 −21 8.07 Patients with AD < controls Medial temporal lobe Rt 38 −26 −9 12.76 Medial temporal lobe Lt −35 −26 −9 11.85 Superior temporal gyrus Lt −61 −50 14 6.90 Patients with DLB > patients with AD Medial temporal lobe Rt 34 −26 −9 5.96 Hippocampus Lt −28 −11 −18 5.14